The Human Equilibrative Nucleoside Transporter 1 (hENT1) mediates the cellular uptake of physiologic nucleosides, including adenosine, as well as many anti-cancer drugs including gemcitabine, cytarabine, and decitabine. Deficiency of hENT1 can lead to resistance of such drugs, and the abundance of hENT1 protein in the plasma membrane is a major indicator of the efficiency and clinical outcome of these anti-cancer nucleosides.

• hENT1 Datasheet IVDR

• MSDS

CLONE:
IHC595

ISOTYPE:
IgG1

HOST SPECIES:
Mouse

CLONALITY:
Monoclonal

POSITIVE CONTROL:
Adrenal Cortex, Kidney, Thyroid, Tonsil, Normal Pancreas

DILUTION RANGE:


INTENDED USE/REG. STATUS:
IVDR